Outcome study of kleptomania patients treated with naltrexone: a chart review.

Clin Neuropharmacol

Department of Psychiatry and Human Behavior, Brown Medical School and Butler Hospital, Providence, Rhode Island 02906, USA.

Published: May 2005

Purpose: This study examines the response to treatment in 17 patients with kleptomania who were treated with naltrexone as monotherapy for up to 3 years.

Methods: Patients were treated with naltrexone (range, 50-200 mg/day) and were assessed at each clinic visit for stealing behavior, urges to steal, and for overall symptom severity. Liver function tests were examined regularly during treatment.

Results: Comparison of baseline symptoms with the most recent follow-up visit showed that 13 patients (76.5%) reported reduction in their urges to steal, and 7 (41.1%) reported no stealing behavior. In addition, 9 (52.9%) were rated as being either "not ill at all" or having "very mild" kleptomania symptoms at the most recent clinic visit. The mean effective dose of naltrexone was 135.3 +/- 38.6 mg/day. Monthly liver function tests revealed no elevations or abnormalities.

Conclusion: These findings from a clinical setting suggest that a substantial percentage of patients report clinically significant improvement in kleptomania symptoms when treated with naltrexone.

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.wnf.0000150868.06512.0bDOI Listing

Publication Analysis

Top Keywords

treated naltrexone
16
patients treated
8
clinic visit
8
stealing behavior
8
urges steal
8
liver function
8
function tests
8
kleptomania symptoms
8
patients
5
naltrexone
5

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!